What are the best treatments for Small Intestine Bacterial Overgrowth (SIBO)?

Small Intestine Bacterial Overgrowth (SIBO) is primarily treated with targeted antibiotic therapy to reduce bacterial load, often complemented by dietary modifications and the management of underlying conditions. Because SIBO is frequently a secondary condition caused by motility issues or structural abnormalities, effective treatment must be highly personalized to address the root cause of the bacterial overgrowth.

What are the first-line treatments for SIBO?

The standard of care for Small Intestine Bacterial Overgrowth (SIBO) focuses on eradicating excessive bacteria in the small bowel. Physicians typically prescribe non-systemic antibiotics that remain primarily in the gastrointestinal tract. The most commonly prescribed antibiotic is rifaximin (Xifaxan), often used for 10–14 days. In cases where methane-predominant Small Intestine Bacterial Overgrowth (SIBO) is suspected, clinicians may combine rifaximin with neomycin or metronidazole to improve efficacy.

What non-pharmacological and dietary treatments are used?

Beyond medication, managing Small Intestine Bacterial Overgrowth (SIBO) often involves specialized diets to limit fermentable carbohydrates that feed intestinal bacteria. Common approaches include:

• Low-FODMAP Diet: Reducing fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage bloating and gas.


• Prokinetic Agents: Medications used to stimulate the Migrating Motor Complex (MMC) to prevent the recurrence of Small Intestine Bacterial Overgrowth (SIBO).


• Lifestyle Modifications: Spacing meals to allow for natural digestive cleansing waves and managing stress, which can impact gut motility.

Which specialists should be on my care team?

Because Small Intestine Bacterial Overgrowth (SIBO) is complex, a multidisciplinary approach is recommended. Your care team should ideally include:

• A Gastroenterologist to oversee diagnostic testing and antibiotic protocols.


• A Registered Dietitian specializing in gastrointestinal health to navigate restrictive diets.


• A Primary Care Physician to coordinate care and investigate underlying systemic triggers.

Are there emerging treatments for SIBO?

Research into Small Intestine Bacterial Overgrowth (SIBO) is evolving rapidly. Current clinical trials are investigating the use of novel prokinetics, specific herbal antimicrobial protocols, and fecal microbiota transplantation (FMT) for refractory cases. Effectiveness varies significantly between patients, particularly based on whether the underlying cause—such as anatomical strictures or autonomic neuropathy—is addressed.

Next steps

• Consult a board-certified gastroenterologist to discuss appropriate breath testing and treatment protocols.


• Keep a detailed food and symptom diary to share with your healthcare provider.


• Join the 30 members currently sharing experiences with Small Intestine Bacterial Overgrowth (SIBO) on DiseaseMaps.org to find community support.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare team before starting any treatment.

References

• NIH National Center for Advancing Translational Sciences (NCATS) - GARD


• North American Consensus on Small Intestinal Bacterial Overgrowth (PubMed)


• The American College of Gastroenterology (ACG) Clinical Guidelines


• International Foundation for Gastrointestinal Disorders (IFFGD)